Omnicell Acquires FDS Amplicare from Calvert Street for $177M

September 1, 2021

Omnicell, Inc. (NASDAQ: OMCL) agreed to acquire pharmacy software provider FDS Amplicare from Calvert Street Capital Partners for $177 million in cash. The acquisition adds FDS Amplicare’s SaaS financial management, analytics, and population health solutions to Omnicell’s EnlivenHealth division to broaden its digital and population-health offerings for retail pharmacies and health plans.

Buyers
Omnicell, Inc.
Targets
FDS Amplicare
Sellers
Calvert Street Capital Partners
Location
Texas, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.